- Home
- HMY vs HALO Comparison
HMY vs HALO Comparison
Compare HMY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- HALO
- Stock Information
- Founded
- HMY 1950
- HALO 1998
- Country
- HMY South Africa
- HALO United States
- Employees
- HMY N/A
- HALO N/A
- Industry
- HMY Precious Metals
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMY Basic Materials
- HALO Health Care
- Exchange
- HMY Nasdaq
- HALO Nasdaq
- Market Cap
- HMY 7.5B
- HALO 7.4B
- IPO Year
- HMY N/A
- HALO N/A
- Fundamental
- Price
- HMY $14.46
- HALO $52.02
- Analyst Decision
- HMY Sell
- HALO Buy
- Analyst Count
- HMY 2
- HALO 9
- Target Price
- HMY $6.60
- HALO $63.56
- AVG Volume (30 Days)
- HMY 5.5M
- HALO 3.1M
- Earning Date
- HMY 01-01-0001
- HALO 05-06-2025
- Dividend Yield
- HMY 1.03%
- HALO N/A
- EPS Growth
- HMY 16.30
- HALO 55.40
- EPS
- HMY 0.88
- HALO 3.76
- Revenue
- HMY $3,553,951,394.00
- HALO $1,084,306,000.00
- Revenue This Year
- HMY $23.09
- HALO $24.79
- Revenue Next Year
- HMY $14.74
- HALO $22.65
- P/E Ratio
- HMY $16.04
- HALO $13.83
- Revenue Growth
- HMY 16.84
- HALO 25.64
- 52 Week Low
- HMY $7.97
- HALO $41.28
- 52 Week High
- HMY $18.77
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- HMY 45.47
- HALO 39.78
- Support Level
- HMY $13.62
- HALO $47.50
- Resistance Level
- HMY $14.50
- HALO $69.94
- Average True Range (ATR)
- HMY 0.47
- HALO 3.52
- MACD
- HMY -0.28
- HALO -1.49
- Stochastic Oscillator
- HMY 28.60
- HALO 19.64
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.